Hopewell Therapeutics, Inc. — Form D/A
Hopewell Therapeutics, Inc. of WOBURN, MA, a company, filed a Form D amendment with the SEC on 2024-05-17. The offering totals $10.0M, of which $7.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-05-17
- Form: D/A
- Accession: 0001836562-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $7.8M
- Remaining: $2.2M
- Investors: 8
- Date of first sale: 2023-05-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-483254
Issuer
- Name: Hopewell Therapeutics, Inc.
- CIK: 0001836562
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 216 WEST CUMMINGS PARK, WOBURN, MA, 01801
- Phone: 617 921 7082
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Thomas Hennessey | Director | Portsmouth, RI |
| Xutian Jing | Director | Woburn, MA |
| Nan Shen | Director | Woburn, MA |
| Jake Xia | Director | New York, NY |
| Qiaobing Xu | Director | Woburn, MA |
| Qiaobing Xu | Executive Officer | Woburn, MA |
| Nan V Shen | Director | Woburn, MA |
| Qiaobing V Xu | Director | Woburn, MA |
| Qiaobing V Xu | Executive Officer | Woburn, MA |
| Thomas V Hennessey, III | Director | Woburn, MA |
| Xiaowen V Femg | Director | Woburn, MA |
| C. Thomas Paschall | Director | Woburn, MA |
| Thomas Hennessey | Executive Officer | Portsmouth, RI |
| Howard Rosen | Director | Woburn, MA |
| XUTIAN V JING | Director | WOBURN, MA |
| THOMAS V HENNESSEY | Director | WOBURN, MA |
| JAKE V XIA | Director | WOBURN, MA |
| HOWARD V ROSEN | Director | WOBURN, MA |
Other filings by this issuer (5)
More